Pressroom

Pressroom: Press Releases

2009

Study Shows Drug Combination Improves Outcome for Advanced Non-Small Cell Lung Cancer

A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC).

May 30, 2009
Surgery Not Necessary for Most Late-Stage Colorectal Cancers

A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don’t require immediate surgery to remove the primary tumor in the colon.

May 30, 2009
Memorial Sloan-Kettering Investigator Named Dream Team Leader by Stand Up To Cancer

Charles Sawyers, MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center and a Howard Hughes Medical Institute investigator, has been named a “Dream Team” leader by Stand Up To Cancer and will co-lead a collaborative team that will receive $15 million to study targeted therapies to treat women’s cancers.

May 27, 2009
Genes Found to Play a Role in Breast Cancer's Spread to the Brain

New research led by investigators at Memorial Sloan-Kettering Cancer Center identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs.

May 6, 2009
New Minimally Invasive Surgery Option for Patients with Stomach Cancer

A novel, minimally invasive surgical approach to treat stomach cancer has been shown to have advantages that may make it a preferable treatment for some patients.

April 15, 2009
Drug Shows Activity in Men with Advanced Prostate Cancer

A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.

April 9, 2009
Genetic Abnormality May Increase Risk of Blood Disorders

Researchers at Memorial Sloan-Kettering Cancer Center have shown for the first time that a tendency to develop some blood disorders may be inherited.

March 15, 2009
NIH Awards $15.9 Million to CCNY and Memorial Sloan-Kettering to Create Partnership to Address Cancer Disparities

The National Institutes of Health’s National Cancer Institute has awarded The City College of New York and Memorial Sloan-Kettering Cancer Center a $15.9 million grant to implement a unique partnership in cancer research, education, and outreach.

February 25, 2009
Nominations Sought for Paul Marks Prize

Nominations are currently being sought for the Paul Marks Prize for Cancer Research.

February 3, 2009
Why Cancer Drugs Are So Expensive and Why Medicare Can't Fix the Problem

A new health policy report which will be published in the New England Journal of Medicine suggests that the swift and dramatic rise in cancer-drug spending is due to laws that keep Medicare from managing the use or price of cancer drugs. These laws limit Medicare’s actions in cancer far more than they are limited in other areas of healthcare.

January 27, 2009
Childhood Cancer Survivors Not Following Recommended Breast Cancer Screening Guidelines

The majority of young women at an increased risk of breast cancer due to chest radiation treatment for childhood cancer are not following breast cancer screening recommendations, according to a recently released, detailed assessment appearing in the January 28, 2009, issue of the Journal of the American Medical Association.

January 27, 2009
Research Shows Cell's Inactive State is Critical for Effectiveness of Cancer Treatment

A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study’s findings, researchers identified the genetic pathway used to maintain a cell’s quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.

January 9, 2009

2008

Researchers Create Smaller, Brighter Probe, Tailored for Clinical Molecular Imaging and Tumor Targeting

Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.

December 22, 2008
New Geoffrey Beene Gift to Memorial Sloan-Kettering Puts Total Support Over $100 Million

Memorial Sloan-Kettering Cancer Center has announced the gift of a membership interest in Geoffrey Beene, LLC, the company that controls the business and fashion empire created by legendary designer Geoffrey Beene.

October 9, 2008
New Study Examines Effectiveness of Colorectal Cancer Screening Tests and Suggests Screening May Be Stopped at Age 75

New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75.

October 6, 2008
Innovative Relationship Advances Cancer Care in New Jersey

Memorial Sloan-Kettering Cancer Center and Summit Medical Group together announce a new collaborative relationship for the care of people with cancer.

October 2, 2008
American Tennis Star James Blake to Launch Cancer Research Fund in His Father's Name at Memorial Sloan-Kettering Cancer Center

American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan-Kettering Cancer Center.

July 10, 2008
Acupuncture Reduces Pain and Dysfunction in Head and Neck Cancer Patients after Neck Dissection

New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection.

May 31, 2008
Drug Fends Off Kidney Cancer Progression

New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.

May 16, 2008
Researchers Learn How Signaling Molecule Orchestrates Breast Cancer's Spread

A study led by researchers at Memorial Sloan-Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.

April 3, 2008
Syndicate content